BLOW: Our child crisis demands political vision
We have a growing crisis among the nation’s children, yet our policies ignore that reality at best and exacerbate it at worst.
We have a growing crisis among the nation’s children, yet our policies ignore that reality at best and exacerbate it at worst.
Thinking of going jungle zip lining or cave tubing anytime soon? Or are you hoping to get up close to lions and elephants on a wildlife safari? Well, now you can buy health insurance to cover you while you take such adventures. Indianapolis-based International Medical Group Inc., which sells health insurance for tourists and expatriates, launched a new product this month with a rider that will cover exactly those kinds of activities. The Patriot Green Group insurance policy is aimed at “international travelers that are committed to sustainable and responsible tourism,” according to a press release from IMG. It makes donations to offset the carbon footprint created by jetting around the world for exotic thrill-seeking. But if a wild adventure proves unsustainable—as when a zip-liner pulls a George of the Jungle and hits a tree—IMG will still help its customers be green even beyond the grave. The Patriot Green Group policy can come with a feature that, when triggered by the customer’s accidental death or dismemberment, will donate $5,000 to “an environmental group that positively impacts global conservation.” Now that takes going green to a whole new dimension.
Butler University’s College of Pharmacy and Health Sciences this fall launched a dual degree for pharmacy students interested in doing research. Students now can earn a doctor of pharmacy degree along with a master’s in pharmaceutical sciences in six years, the same time frame required for the doctorate alone. Butler launched a similar dual degree in 2003, which combined a doctorate in pharmacy and an MBA degree.
Every business sector has influential players, whether they are in the public eye or wield their influence behind the scenes. This month, IBJ zeroes in on Health Care and Benefits.
As the season begins, we can’t help but think about where it will end—Lucas Oil Stadium—and who might be playing in the Super Bowl.
Both candidates for Indianapolis mayor are touting a host of ways to improve the city’s business climate. Incumbent Greg Ballard champions improving the city’s amenities. Challenger Melina Kennedy focuses on recruiting entrepreneurs to the city.
Democrat Andre Carson of Indianapolis, a black congressman, used a lynching metaphor to describe tea party policies he says would turn minorities into “second class citizens.”
Indiana has hired an outside firm to help with its investigation into a fatal stage collapse at the state fair after questions were raised about the state's ability to conduct an objective probe itself.
With reluctance, Mike Alley, a veteran Indianapolis banker, joined the board of Evansville-based Integra Bank in April 2009. A month later, he found himself CEO—the beginning of a 26-month odyssey that ended July 29 with banking regulators seizing and shutting down the 160-year-old institution.
The latest prolonged recession intensified the push for U.S. productivity gains.
Researchers at the Indiana University School of Medicine plan to launch a large clinical trial of an experimental two-drug combination for treating late-stage ovarian cancer. The drug combo produced a positive effect in 70 percent of patients in a Phase 2 trial and the IU researchers said they may have discovered biomarkers that could help identify women who would respond best to the therapy. The therapy combines two chemotherapy agents, decitabine with carboplatin. The IU researchers, led by Dr. Daniela Matei, are using it for women who have become resistant to carboplatin after multiple rounds of chemotherapy. IU is now seeking grant funding for a Phase 3 trial, in which the combo therapy will be compared against other approved therapies for ovarian cancer. Their research has been supported by the National Institutes of Health, National Cancer Institute, Walther Cancer Foundation in Indianapolis and the Ovarian Cancer Research Foundation.
DePuy Orthopaedics Inc. plans to spend $27 million on manufacturing and research equipment to grow its orthopedic implant operation in Warsaw, Ind. The expansion will add no jobs to DePuy’s 1,100-person work force, but the Warsaw City Council has approved a 10-year property tax abatement on the equipment. DePuy spokeswoman Jessica Masuga told The Journal Gazette of Fort Wayne that the equipment will improve efficiency. DePuy is a subsidiary of New Jersey-based Johnson & Johnson.
West Lafayette-based Endocyte Inc. raised about $66.8 million in a secondary public offering of nearly 6.7 million shares of company stock. Shares for the offering, which began in mid-July, were priced at $12.26 each. Endocyte, which also has offices in Indianapolis, said it intends to seek permission to sell its ovarian cancer drug in Europe on a limited basis. The decision to proceed came after consultation with the European Medicines Agency and written advice from the regulators, Endocyte said in April. Endocyte shares had more than doubled in price after its initial public offering in February, before sliding in the recent market-wide decline in stocks.
Rochester Medical Implants will move its 28 employees from Rochester to Noblesville. Fulton Economic Development Corp. director Terry Lee said company officials attributed the decision to an inability to recruit needed employees to Rochester and better proximity to customers in the Indianapolis area. The Rochester Sentinel reported that a company co-owner had previously discussed plans for expanding on its eight-acre site in that city. Lee said some of the company's workers plan on transferring to the new location, with the move expected to happen by October. Rochester is about 75 miles north of Noblesville.
Former Indiana University President John W. Ryan, who oversaw the creation of two regional IU campuses during his 16-year tenure and had a hand in the university's development spanning 50 years, died early Saturday at age 81, school officials said.
A crisis-conquering deficit-reduction agreement struck by the White House and congressional leaders after months of partisan rancor picked up momentum Monday.
This month, we recognize the power players who built this city, from the new airport to Lucas Oil Stadium to the Palladium.
The Indiana Department of Environmental Management says an inspection of the State of Indiana Forensic and Health Sciences Lab found open jugs of hazardous materials during an inspection.
The hospital system said it will expand its Medical Center Northeast facility to a 40-bed inpatient hospital. Construction is set to begin in September and should be completed by December 2012.
For many legislators, the purpose of being in Congress is not to pass laws. It’s to create clear contrasts you can take into the next election campaign.
We often forget that as a society there are real advantages to working (and investing) together for a common purpose.
Partners at Indianapolis’ three largest law firms—Barnes & Thornburg LLP, Baker & Daniels LLP and Ice Miller LLP—are enjoying healthy pay increases despite the tough economic times.
The debate over Medicaid funding and Planned Parenthood is about the access of poor people to health care. And about the right of the state of Indiana to assert the power to say where poor people can receive such health care services.